 | Up a level |
Journal Article
Faetkenheuer, G., Jessen, H., Stoehr, A., Jung, N., Jessen, A. B., Kuemmerle, T., Berger, M., Bogner, J. R., Spinner, C. D., Stephan, C., Degen, O., Vogelmann, R., Spornraft-Ragaller, P., Schnaitmann, E., Jensen, B., Ulmer, A., Kittner, J. M., Haerter, G., Malfertheiner, P., Rockstroh, J., Knecht, G., Scholten, S., Harrer, T., Kern, W. V., Salzberger, B., Schuermann, D. and Ranneberg, B. (2016). PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis. HIV Med., 17 (6). S. 453 - 460. HOBOKEN: WILEY. ISSN 1468-1293
Michalik, C., Soennerborg, A., Jansen, K., Svedhem-Johansson, V, Harrer, T., Thalme, A., Eychenne, J. and Jimenez-Exposito, M. (2012). ATV/r-based regimens: durable virological suppression and good tolerability as switch strategy from NNRTI-containing regimens in a real-life cohort. J. Int. AIDS Soc., 15. S. 163 - 165. CHICHESTER: JOHN WILEY & SONS LTD. ISSN 1758-2652
Riebold, D., Stocker, H., Koehler, P., Bauer, T. T., Kroegel, C., Harrer, T. and Slevogt, H. (2020). Study: P. jirovecii Pathogen Quantification and Resistance Testing in Patients with Pneumocystis pneumonia (PCP) and Pneumocystis Colonization. Mycoses, 63. S. 14 - 15. HOBOKEN: WILEY. ISSN 1439-0507